Notice2026-05280
Preparation for International Cooperation on Cosmetics Regulation Twentieth Annual Meeting (ICCR-20); Request for Comments
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
March 18, 2026
Issuing agencies
Health and Human Services DepartmentFood and Drug Administration
Abstract
The Food and Drug Administration (FDA, the Agency, or we) is soliciting comments from the public on various topics pertaining to the regulation of cosmetics in preparation for the twentieth International Cooperation on Cosmetics Regulation annual meeting (ICCR-20). We may use this input to help us prepare for the ICCR-20 meeting that will be held July 7 to 9, 2026, in Tokyo, Japan.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 52 (Wednesday, March 18, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 52 (Wednesday, March 18, 2026)]
[Notices]
[Pages 13030-13031]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-05280]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2026-N-2279]
Preparation for International Cooperation on Cosmetics Regulation
Twentieth Annual Meeting (ICCR-20); Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is
soliciting comments from the public on various topics pertaining to the
regulation of cosmetics in preparation for the twentieth International
Cooperation on Cosmetics Regulation annual meeting (ICCR-20). We may
use this input to help us prepare for the ICCR-20 meeting that will be
held July 7 to 9, 2026, in Tokyo, Japan.
DATES: Either electronic or written comments on this notice must be
submitted by May 18, 2026.
ADDRESSES: You may submit comments as follows. Please note that late,
untimely filed comments will not be considered. The <a href="https://www.regulations.gov">https://www.regulations.gov</a> electronic filing system will accept comments until
11:59 p.m. Eastern Time at the end of May 18, 2026. Comments received
by mail/hand delivery/courier (for written/paper submissions) will be
considered timely if they are received on or before that date.
Electronic Submissions
Submit electronic comments in the following way:
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to <a href="https://www.regulations.gov">https://www.regulations.gov</a>
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
<bullet> If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
<bullet> Mail/Hand Delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
<bullet> For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2026-N-2279 for ``Preparation for International Cooperation on
Cosmetics Regulation Twentieth Annual Meeting (ICCR-20); Request for
Comments.'' Received comments, those filed in a timely manner (see
ADDRESSES), will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at <a href="https://www.regulations.gov">https://www.regulations.gov</a> or at the Dockets Management Staff between 9 a.m.
and 4 p.m., Monday through Friday, 240-402-7500.
<bullet> Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Submit both copies to the Dockets Management Staff. If you do not wish
your name and contact information to be made publicly
[[Page 13031]]
available, you can provide this information on the cover sheet and not
in the body of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: <a href="https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf">https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf</a>.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Deborah Smegal, Office of Cosmetics
and Colors, Office of the Chief Scientist, Food and Drug
Administration, 5001 Campus Dr., College Park, MD 20740, 240-402-1818,
<a href="/cdn-cgi/l/email-protection#9fdbfafdf0edfef7b1ccf2faf8fef3dff9fbfeb1f7f7ecb1f8f0e9"><span class="__cf_email__" data-cfemail="7d39181f120f1c15532e10181a1c113d1b191c5315150e531a120b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
I. Background
The intention of the International Cooperation on Cosmetics
Regulation (ICCR) multilateral framework is to pave the way for the
removal of regulatory obstacles to international trade while
maintaining global consumer protection. FDA is soliciting comments from
the public on various topics pertaining to the regulation of cosmetics.
We may use this input to help us prepare for the twentieth ICCR annual
meeting (ICCR-20) that will be held July 7 to 9, 2026, in Tokyo, Japan.
ICCR is a voluntary international group of cosmetics regulatory
authorities, including the United States. These regulatory authority
members will engage in dialogue with their relevant cosmetics industry
trade associations and other interested parties. The current ICCR
members can be found at: <a href="https://www.iccr-cosmetics.org/">https://www.iccr-cosmetics.org/</a>. The ICCR
generally operates on a consensus-based decision-making process (see
<a href="https://www.iccr-cosmetics.org/topics-documents/4-iccr-governance">https://www.iccr-cosmetics.org/topics-documents/4-iccr-governance</a>). All
decisions will be compatible with the laws, policies, rules,
regulations, and directives of the respective administrations and
governments of the ICCR members. Members will implement and/or promote
actions or documents within their own jurisdictions and seek
convergence of regulatory policies and practices. Successful
implementation will need input from interested parties.
ICCR considers various topics of common interest and relevance for
cosmetics (see <a href="https://www.iccr-cosmetics.org/topics-documents">https://www.iccr-cosmetics.org/topics-documents</a>).
II. Request for Comments
FDA is requesting public comment on the following questions related
to topics identified for the ICCR-20 meeting.\1\ FDA is also requesting
public comment on any additional cosmetics topics of interest for
consideration by ICCR for future work.
---------------------------------------------------------------------------
\1\ Topics for the ICCR-20 meeting were identified at the ICCR-
19 meeting held on July 8 to 10, 2025, in Ottawa, Ontario, Canada.
Outcomes of the ICCR-19 meeting are available at <a href="https://www.iccr-cosmetics.org/component/attachments/attachments?id=175&task=download">https://www.iccr-cosmetics.org/component/attachments/attachments?id=175&task=download</a>.
---------------------------------------------------------------------------
1. What new International Organization for Standardization (ISO)
standards and technical reports should be considered for inclusion in
the Updated Annex of International Standards in Cosmetics Report (Ref.
1)?
2. What new non-animal testing methods should be considered for
inclusion in the Inventory of Validated Non-Animal Testing Methods
Applicable for Cosmetic Products and their Ingredients in all ICCR
Regions (Ref. 2)?
3. What are your suggestions to help make risk assessment using
non-animal data a more common approach for safety assessments of
cosmetic ingredients?
4. What general principles should be considered for electronic
labeling (e-labeling) and digital information for cosmetics across ICCR
member jurisdictions?
5. What are common questions and misconceptions and ways to improve
understanding related to cosmetics use, safety, and regulation that
arise across ICCR member jurisdictions?
6. What are your suggestions for any changes to or considerations
for ICCR's purpose, mission, and future direction?
III. References
The following references are on display at the Dockets Management
Staff (see ADDRESSES) and are available for viewing by interested
persons between 9 a.m. and 4 p.m., Monday through Friday; they are also
available electronically at <a href="https://www.regulations.gov">https://www.regulations.gov</a>. Although FDA
verified the website addresses in this document, please note that
websites are subject to change over time.
1. ICCR, ``Updated Annex of International Standards in Cosmetics
Report.'' 2025. Accessed March 4, 2026. Available at: <a href="https://www.iccr-cosmetics.org/component/attachments/?task=download&id=181">https://www.iccr-cosmetics.org/component/attachments/?task=download&id=181</a>.
2. ICCR, ``Inventory of Validated Non-Animal Testing Methods
Applicable for Cosmetic Products and their Ingredients in all ICCR
Regions.'' 2025. Accessed March 4, 2026. Available at: <a href="https://www.iccr-cosmetics.org//downloads/topics/2025-updated%20annex%20of%20validated%20non-animal%20testing%20methods%20applicable%20for%20cosmetics.pdf">https://www.iccr-cosmetics.org//downloads/topics/2025-updated%20annex%20of%20validated%20non-animal%20testing%20methods%20applicable%20for%20cosmetics.pdf</a>.
Grace R. Graham,
Deputy Commissioner for Policy, Legislation, and International Affairs.
[FR Doc. 2026-05280 Filed 3-17-26; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on March 18, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.